Cleopatra-PD: Clinical efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease

被引：0

作者：

Poewe, W. H. ^{[1
]}

Rascol, O. ^{[2
]}

Quinn, N. ^{[3
]}

Tolosa, E. ^{[4
]}

Oertel, W. H. ^{[5
]}

Martignoni, E. ^{[6
]}

Rupp, M. ^{[7
]}

Boroojerdi, B. ^{[7
]}

机构：

[1] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria

[2] Ctr Hosp Univ, Serv Pharmacol Clin, Toulouse, France

[3] UCL, Inst Neurol, London, England

[4] Hosp Clin Univ, Serv Neurol, Barcelona, Spain

[5] Univ Marburg, Dept Neurol, Marburg, Germany

[6] Univ Piemonte Orientale, Novara, Italy

[7] Schwarz Pharma, Monheim, Germany

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2007年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：11 / 11

页数：1

共 50 条

[31] Efficacy and safety of 24 hour rotigotine transdermal patch in the treatment of advanced Parkinson's disease: A meta-analysis
Ramiro, G. M. I.
Fabiania, N. L.
Jamora, R. D. G.
MOVEMENT DISORDERS, 2013, 28 : S214 - S214
[32] Advanced Parkinson disease treated with rotigotine transdermal system - PREFER Study
LeWitt, Peter A.
Lyons, Kelly E.
Pahwa, Rajesh
NEUROLOGY, 2007, 68 (16) : 1262 - 1267
[33] Rotigotine transdermal system for perioperative administration in Parkinson's disease
Wuellner, U.
Haeck, H. J.
Boroojerdi, B.
Reichmann, H.
JOURNAL OF NEUROLOGY, 2009, 256 : S16 - S16
[34] Long-Term Safety and Tolerability of Transdermal Rotigotine in Patients with Advanced Parkinson's Disease
Poewe, Werner
Rascol, Olivier
Quinn, Niall
Tolosa, Eduardo
Oertel, Wolfgang
Giladi, Nir
Boroojerdi, Babak
NEUROLOGY, 2009, 72 (11) : A321 - A321
[35] Efficacy of rotigotine transdermal patch as adjunct to levodopa in subgroups of advanced-stage Parkinson's patients
LeWitt, P.
PARKINSONISM & RELATED DISORDERS, 2007, 13 : S110 - S110
[36] Pramipexole in the treatment of advanced Parkinson's disease
不详
HOSPITAL MEDICINE, 1999, 60 (04): : 308 - 308
[37] Pramipexole in the treatment of advanced Parkinson's disease
Möller, JC
Oertel, WH
EUROPEAN JOURNAL OF NEUROLOGY, 2000, 7 : 21 - 25
[38] An open-label study on switching therapy from pramipexole or ropinirole to rotigotine transdermal system in subjects with advanced-stage, idiopathic Parkinson's disease
Kim, J. M.
Chung, S. J.
Kim, J. W.
Jeon, B. S.
Bauer, L.
Thierfelder, S.
MOVEMENT DISORDERS, 2013, 28 : S175 - S175
[39] The long-term safety and efficacy of pramipexole in advanced Parkinson's disease
Weiner, WJ
Factor, SA
Jankovic, J
Hauser, RA
Tetrud, JW
Waters, CH
Shulman, LM
Glassman, PM
Beck, B
Paume, D
Doyle, C
PARKINSONISM & RELATED DISORDERS, 2001, 7 (02) : 115 - 120
[40] Efficacy and safety of pramipexole extended-release for advanced Parkinson's disease
Schapira, A.
Barone, P.
Hauser, R. A.
Mizuno, Y.
Poewe, W.
Rascol, O.
Busse, M.
Juhel, N.
MOVEMENT DISORDERS, 2009, 24 : S277 - S278

← 1 2 3 4 5 →